| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Roivant Sciences Ltd. (ROIV) has 15 insiders with recent SEC Form 4 filings, including 28 buys and 0 sells. ROIV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $3.54B | - | |
| 10% | 33.65M | $1.05B | - | |
| Pres | 18.68M | $583.68M | - | |
| CEO | 16.74M | $523.00M | - | |
| Dir | 15.35M | $479.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 19, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 18,204 | $8.32 | $151,380.99 | - | |
| Jun 14, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 22,011 | $8.06 | $177,300.64 | - | |
| Jun 11, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 21,338 | $8.31 | $177,247.38 | - | |
| Jun 6, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 21,122 | $7.86 | $165,950.15 | - | |
| Jun 4, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 2,424,242 | $8.25 | $19,999,996.50 | +6.3% | |
| Jun 3, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 17,746 | $7.83 | $138,946.36 | - | |
| May 29, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 14,485 | $7.63 | $110,461.18 | - | |
| May 23, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 19,830 | $8.22 | $162,918.35 | - | |
| May 20, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 21,608 | $7.54 | $162,884.29 | - | |
| Mar 18, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 6,666,667 | $1.50 | $10,000,000.50 | +6.7% |